YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Analysis of the Clinical and Demographic Data of the Patients Diagnosed With Myastenia Gravis Followed-Up in Our Clinic

dc.authorscopusid 56368632300
dc.authorscopusid 55237712400
dc.contributor.author Yılgör, A.
dc.contributor.author Baydar, C.
dc.date.accessioned 2025-05-10T16:55:00Z
dc.date.available 2025-05-10T16:55:00Z
dc.date.issued 2023
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Yılgör A., Yuzuncu Yıl Unıversıty Medical School, Neurology Department, Van, Turkey; Baydar C., Yuzuncu Yıl Unıversıty Medical School, Neurology Department, Van, Turkey en_US
dc.description.abstract Objective: The objective of this study is to evaluate the demographic characteristics as well as the clinical course, antibod y, and electrophysiological characteristics of the patients diagnosed with Myastenia Gravis (MG ) followed-up in our clinic. Material and Method: The demographic characteristics as well as the radiological characteristics, clinical follow-ups, antibody results and electrophysiological characteristics of 99 MG patients followed-up in our Neuromuscular and Muscle Diseases Outpatient Clinic for a period of 5 years are examined. Findings: The mean age of the patients was 44,38±15,2. The number of patients followed-up as isolated ocular MG was 22,22% (n=22). Acetylcholine receptor antibody (AntiAChRAb) was found positive in 53,54% (n=53) of the patients and thymus pathology (Thymoma + post-thymectomy thymic hyperplasia) was found in the thoracic tomography of 42,42% (n=42) of the patients. Result: Although the pathologies in the development of MG are well known, in some cases, there may be some problems in the follow-up and treatment of MG patients. Therefore, detailed patient follow-up and long-term clinical monitoring is important in MG patients. There are some limitations due to the fact that this is a h ospital-based study. An example of such limitations is the lack of data related to responses to the treatment. More extensive epidemiological studies on this matter will be more informative. Detailed patient file recording and administration of individuali zed treatments will provide positive results in the long term in MG patients who suffer from a chronic disease which progress with flare ups. © 2023, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved. en_US
dc.identifier.doi 10.5505/ejm.2023.15707
dc.identifier.endpage 782 en_US
dc.identifier.issn 1301-0883
dc.identifier.issue 4 en_US
dc.identifier.scopus 2-s2.0-85176801092
dc.identifier.scopusquality Q4
dc.identifier.startpage 778 en_US
dc.identifier.trdizinid 1263541
dc.identifier.uri https://doi.org/10.5505/ejm.2023.15707
dc.identifier.uri https://hdl.handle.net/20.500.14720/3319
dc.identifier.volume 28 en_US
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.publisher Yuzuncu Yil Universitesi Tip Fakultesi en_US
dc.relation.ispartof Eastern Journal of Medicine en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Acetylcholine Receptor en_US
dc.subject Myastenia Gravis en_US
dc.subject Thymoma en_US
dc.title Analysis of the Clinical and Demographic Data of the Patients Diagnosed With Myastenia Gravis Followed-Up in Our Clinic en_US
dc.type Article en_US

Files